Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)

China flag China · Delayed Price · Currency is CNY
29.73
+0.20 (0.68%)
Apr 29, 2026, 3:00 PM CST
76.75%
Market Cap 13.17B
Revenue (ttm) 910.06M
Net Income (ttm) 50.96M
Shares Out 442.94M
EPS (ttm) 0.13
PE Ratio 237.84
Forward PE n/a
Dividend 0.06 (0.20%)
Ex-Dividend Date n/a
Volume 7,000,047
Average Volume 9,981,618
Open 29.56
Previous Close 29.53
Day's Range 29.15 - 30.15
52-Week Range 16.61 - 44.99
Beta 0.81
RSI 45.95
Earnings Date Mar 31, 2026

About SHA:688321

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research and development of original small molecule drugs. The company develops Chidamide, a subtype-selective histone deacetylase inhibitor for the treatment of peripheral T-cell lymphoma and advanced hormone receptor-positive breast cancer; Chiglitazar Sodium, a PPAR pan-agonist for the treatment of metabolic diseases; and Chiauranib, a triple-pathway tumor-targeting inhibitor. It is also developing CS23546, a small-molecule PD-L1 inhibitor; CS231295, a brain-penetrant Aurora B selectiv... [Read more]

Sector Healthcare
Founded 2001
Employees 1,002
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688321
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.